Table 2 Characteristics and univariate analysis of factors influencing 1-year mortality after hip fracture surgery. Data are expressed as median [interquartile space] or numbers (proportions). ADL, Activity of Daily Living; ASA, American Society of Anesthesiologists; BMI, Body Mass Index; AKI, Acute Kidney Injury.

From: Risk factors and mortality of patients undergoing hip fracture surgery: a one-year follow-up study

 

Alive (n = 231)

Dead (n = 78)

P value

Male gender (n; %)

57 (25)

25 (32)

0.202

Age (year)

   

<65

26 (11)

3 (4)

0.001

66–75

44 (19)

5 (6)

 

76–85

76 (33)

24 (31)

 

>85

85 (37)

46 (59)

 

BMI (kg m−2)

23.9 [21.1–27.0]

22.5 [21.1–27.0]

0.033

Albumin level (g l−1)

   

<20

12 (5)

4 (5)

0.604

20–30

89 (38)

37 (47)

 

 > 30

99 (44)

31 (40)

 

Missing data

31 (13)

6 (8)

 

Pre-fracture functional status

   

Full independence

24 (10)

15 (19)

<0.001

Partial dependence

25 (11)

12 (15)

 

Total dependence

77 (34)

7 (9)

 

Missing data

105 (45)

54 (69)

 

ASA status

   

1

8 (3)

0 (0)

<0.001

2

81 (35)

10 (13)

 

3

133 (58)

59 (76)

 

4

9 (4)

8 (11)

 

Lee

   

0

136 (59)

26 (33)

<0.001

1

62(27)

28 (36)

 

2

27 (12)

14 (18)

 

3

6 (2)

10 (13)

 

Surgery time (minutes)

54 [41–65]

47 [36–60]

0.035

Type of anaesthesia

   

General anaesthesia

118 (51)

38 (49)

0.744

Regional

28 (13)

12(16)

 

Combined

84 (36)

27 (35)

 

Prosthesis type (n; %)

   

Total hip arthroplasty

38 (16)

1(1)

0.003

Hemiarthroplasty

78 (34)

38 (49)

 

Dynamic hip screw

66 (29)

19 (25)

 

Gamma nail

45 (19)

16 (21)

 

Others

4 (2)

3 (4)

 

Residential status (n; %)

   

Own home

173 (75)

42 (54)

<0.001

Nursing home

58 (25)

36 (46)

 

Blood cell transfusion (n; %)

59 (25)

27 (35)

0.232

Time to surgery (n; %)

   

≤ 48 hours

105 (45)

23 (29)

0.009

 > 48 hours

126 (55)

55 (71)

 

Hospital discharge (days)

8 [6–10]

8.5 [6.2–12]

0.004

Perioperative complication (n; %)

50 (22)

20 (26)

0.280

AKI (Serum creatinine>1.5 baseline or increase>26.5 mmol/l) (n; %)

9 (4)

1 (1)

0.280